➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Merck
Johnson and Johnson
Dow

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Litigation Details for Sudenga Industries Inc v. Global Industries Inc (D. Kan. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Sudenga Industries Inc v. Global Industries Inc (D. Kan. 2018)

Docket   Start Trial Date Filed 2018-09-14
Court District Court, D. Kansas Date Terminated
Cause 35:271 Patent Infringement Assigned To
Jury Demand Referred To
Patents 10,010,611; 10,010,632; 10,011,637; 10,016,421; 10,022,379; 10,029,389; 10,048,258; 10,052,389; 10,071,281; 10,081,673; 10,081,681; 10,085,997; 10,087,237; 10,087,253; 10,087,495; 10,088,479; 10,119,979; 10,137,167; 10,167,254; 10,167,331; 10,167,486; 10,232,051; 10,232,061; 10,234,118; 10,253,042; 10,253,076; 10,253,077; 10,253,095; 10,253,102; 10,253,268; 10,253,331; 10,254,139; 10,258,637; 10,260,097; 10,338,039; 10,426,091; 10,486,041; 10,486,043; 10,632,143; 6,095,253; 6,102,426; 6,161,260; 6,162,648; 6,255,066; 6,255,067; 6,297,425; 6,426,110; 6,448,080; 6,479,065; 6,620,382; 6,640,530; 6,982,101; 7,005,253; 7,037,540; 7,060,673; 7,067,292; 7,074,234; 7,122,149; 7,122,530; 7,131,253; 7,235,530; 7,260,062; 7,267,979; 7,268,156; 7,297,077; 7,297,136; 7,442,389; 7,479,136; 7,479,254; 7,495,030; 7,495,103; 7,637,260; 7,820,142; 7,820,203; 7,820,681; 7,982,018; 7,982,043; 7,982,049; 7,982,075; 7,982,076; 7,982,077; 7,982,078; 7,982,093; 8,003,673; 8,003,681; 8,026,267; 8,030,297; 8,030,538; 8,034,997; 8,039,479; 8,041,421; 8,053,448; 8,062,632; 8,071,648; 8,074,495; 8,080,530; 8,083,620; 8,084,426; 8,088,979; 8,093,258; 8,097,252; 8,097,648; 8,101,161; 8,119,648; 8,137,235; 8,143,237; 8,143,425; 8,148,076; 8,232,053; 8,232,281; 8,252,331; 8,252,979; 8,253,049; 8,258,094; 8,258,095; 8,258,102; 8,258,118; 8,258,268; 8,268,008; 8,338,088; 8,338,100; 8,338,479; 8,338,486; 8,338,648; 8,379,486; 8,389,021; 8,389,110; 8,426,389; 8,426,426; 8,426,586; 8,486,032; 8,486,116; 8,530,425; 8,586,005; 8,586,020; 8,586,038; 8,586,044; 8,586,045; 8,586,078; 8,586,084; 8,586,093; 8,586,103; 8,637,002; 8,637,014; 8,637,026; 8,637,029; 8,637,030; 8,637,079; 8,637,084; 8,637,096; 8,637,306; 8,637,540; 8,648,037; 8,648,038; 8,648,048; 8,648,077; 8,648,093; 8,648,095; 8,648,098; 8,648,122; 8,669,051; 8,669,281; 8,979,271; 9,005,616; 9,017,681; 9,023,616; 9,051,260; 9,061,267; 9,062,258; 9,062,331; 9,073,997; 9,078,690; 9,081,237; 9,085,620; 9,090,640; 9,096,681; 9,101,540; 9,101,637; 9,101,669; 9,139,632; 9,145,389; 9,145,426; 9,149,486; 9,149,530; 9,234,032; 9,234,033; 9,234,041; 9,254,267; 9,255,068; 9,255,087; 9,255,094; 9,255,143; 9,258,035; 9,258,997; 9,267,148; 9,382,297; 9,421,166; 9,486,426; 9,486,530; 9,540,382; 9,540,425; 9,586,010; 9,586,083; 9,616,024; 9,616,028; 9,616,031; 9,616,043; 9,616,044; 9,616,049; 9,616,059; 9,616,061; 9,616,066; 9,616,088; 9,616,090; 9,616,096; 9,616,097; 9,616,126; 9,616,137; 9,616,145; 9,616,148; 9,669,008; 9,669,009; 9,669,023; 9,669,024; 9,669,026; 9,669,068; 9,669,074; 9,669,089; 9,669,093; 9,669,094; 9,669,096; 9,669,136; 9,982,010; 9,982,029; 9,982,030; 9,982,031; 9,982,032; 9,982,049; 9,982,050; 9,982,051
Link to Docket External link to docket
Biologic Drugs cited in Sudenga Industries Inc v. Global Industries Inc

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Sudenga Industries Inc v. Global Industries Inc (D. Kan. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-15 131 Order on Motion to Compel 1269. 62 Black & Veatch Corp., 297 F.R.D. 611, 620 (D. Kan. 2014). 63 Marten v. Yellow Freight…about a patent application were not privileged. The in-house counsel there was a French patent agent.45… the patent application was not legal advice, and legal services were not sought from the patent agent…American courts have extended a patent-agent privilege to Canadian patent agents who are attorneys and …attorney, to a patent agent, and argues “the basic principles are the same for attorneys and patent agents authorized External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Medtronic
McKesson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.